Allegion plc (FRA:60A)
Germany · Delayed Price · Currency is EUR 143.00
0.00 (0.00%)
At close: Aug 1, 2025, 10:00 PM CET
CTI BioPharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 626.2 | 597.5 | 540.4 | 458 | 483 | 314.3 | Upgrade |
Depreciation & Amortization | 106.9 | 104.5 | 98.7 | 85.6 | 71.6 | 67.5 | Upgrade |
Other Amortization | 14.5 | 14.5 | 12.9 | 12.3 | 11.5 | 13.5 | Upgrade |
Loss (Gain) From Sale of Assets | - | - | - | 7.1 | - | 37.3 | Upgrade |
Asset Writedown & Restructuring Costs | - | - | 7.5 | - | - | 101.7 | Upgrade |
Loss (Gain) From Sale of Investments | 1 | 1 | 0.8 | 0.2 | -25.6 | 2 | Upgrade |
Stock-Based Compensation | 28.2 | 28.2 | 26.4 | 24.5 | 23.4 | 20.8 | Upgrade |
Other Operating Activities | -46.6 | -46.6 | -68.3 | -58.4 | -35.1 | -30.6 | Upgrade |
Change in Accounts Receivable | -6.7 | -6.7 | -11.9 | -53.4 | 31.7 | -1.9 | Upgrade |
Change in Inventory | 16.7 | 16.7 | 44.6 | -61.7 | -105.6 | -7.8 | Upgrade |
Change in Accounts Payable | 3.6 | 3.6 | -33.6 | 2.5 | 40 | -1.6 | Upgrade |
Change in Other Net Operating Assets | 21.3 | -37.7 | -16.9 | 42.8 | -6.3 | -24.9 | Upgrade |
Operating Cash Flow | 765.1 | 675 | 600.6 | 459.5 | 488.6 | 490.3 | Upgrade |
Operating Cash Flow Growth | 28.68% | 12.39% | 30.71% | -5.96% | -0.35% | 0.43% | Upgrade |
Capital Expenditures | -82.8 | -92.1 | -84.2 | -64 | -45.4 | -47.1 | Upgrade |
Cash Acquisitions | -63.8 | -137.2 | -31.7 | -923.1 | -6.5 | -12.5 | Upgrade |
Investment in Securities | - | - | - | - | 7.6 | - | Upgrade |
Other Investing Activities | 1.6 | 0.9 | -13.2 | -7 | 12.7 | 2.9 | Upgrade |
Investing Cash Flow | -145 | -228.4 | -129.1 | -994.1 | -31.6 | -56.7 | Upgrade |
Long-Term Debt Issued | - | 400 | 30 | 940 | 250 | - | Upgrade |
Total Debt Issued | 76 | 400 | 30 | 940 | 250 | - | Upgrade |
Long-Term Debt Repaid | - | -413.3 | -111.6 | -283.6 | -238.9 | -0.2 | Upgrade |
Total Debt Repaid | -416.3 | -413.3 | -111.6 | -283.6 | -238.9 | -0.2 | Upgrade |
Net Debt Issued (Repaid) | -340.3 | -13.3 | -81.6 | 656.4 | 11.1 | -0.2 | Upgrade |
Issuance of Common Stock | 14.7 | 14.7 | 1.3 | - | - | - | Upgrade |
Repurchase of Common Stock | -220 | -220 | -59.9 | -64.3 | -412.8 | -208.8 | Upgrade |
Common Dividends Paid | -171 | -167 | -158.7 | -143.9 | -129 | -117.3 | Upgrade |
Other Financing Activities | -5.3 | -8.9 | 0.2 | -11.2 | 1.4 | 4.4 | Upgrade |
Financing Cash Flow | -721.9 | -394.5 | -298.7 | 437 | -529.3 | -321.9 | Upgrade |
Foreign Exchange Rate Adjustments | 11.1 | -16.4 | 7.3 | -12.3 | -10.2 | 10 | Upgrade |
Net Cash Flow | -90.7 | 35.7 | 180.1 | -109.9 | -82.5 | 121.7 | Upgrade |
Free Cash Flow | 682.3 | 582.9 | 516.4 | 395.5 | 443.2 | 443.2 | Upgrade |
Free Cash Flow Growth | 35.84% | 12.88% | 30.57% | -10.76% | - | 4.88% | Upgrade |
Free Cash Flow Margin | 17.60% | 15.45% | 14.14% | 12.09% | 15.46% | 16.30% | Upgrade |
Free Cash Flow Per Share | 7.85 | 6.65 | 5.85 | 4.48 | 4.90 | 4.78 | Upgrade |
Cash Interest Paid | 100.3 | 100.3 | 92 | 56.9 | 45.1 | 47.3 | Upgrade |
Cash Income Tax Paid | 158.3 | 158.3 | 157.9 | 81.7 | 89.1 | 82.6 | Upgrade |
Levered Free Cash Flow | 548.98 | 465.74 | 463.55 | 295.2 | 378.99 | 361.91 | Upgrade |
Unlevered Free Cash Flow | 613.54 | 529.49 | 521.74 | 342.64 | 410.36 | 393.85 | Upgrade |
Change in Net Working Capital | -29.1 | 20.8 | -8 | 107.2 | -10.7 | 5.5 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.